This trial is testing whether a higher dose of radiation to areas of the tumor that are more active will reduce the rate of the cancer coming back in 2 years.
1 Primary · 8 Secondary · Reporting Duration: 2 years
78 Total Participants · 2 Treatment Groups
Primary Treatment: Chemoradiotherapy with Integrated Boost Dose · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: